The Neuromuscular Junction: How a Nerve Commands a Muscle
A nerve never actually touches the muscle it controls. It stops just short and shouts a chemical word across a gap thinner than a wavelength of light. Press play and watch the whole handshake: a nerve spike arrives, calcium floods in, vesicles dump acetylcholine across the cleft, the muscle’s end plate fires, and an enzyme instantly wipes the message clean so the next command can land. This one tiny junction is where Botox, curare, myasthenia gravis and nerve agents all do their work — so break it four different ways and see exactly what each one changes.
Try this: let it run on Normal signal and watch one clean twitch per command — then switch to Nerve agent and see the acetylcholine meter pin to the top while the muscle fires over and over with no off-switch.
Live junction readout
What's happening
Only the labelled voltages are real clinical values (skeletal-muscle resting potential ≈−90 mV, firing threshold ≈−50 mV, muscle-spike peak ≈+30 mV, cleft ≈50 nm, ACh cleared in <1 ms). The two meters marked “model” and the twitch counts are an illustrative teaching model of relative acetylcholine and calcium levels — not measured molecule counts.
The Science in Plain Language
A nerve never touches the muscle it commands
It comes close — heartbreakingly close — and then stops. Between the tip of the motor nerve and the surface of the muscle lies a gap called the synaptic cleft, only about 50 nanometres wide. That is roughly a thousandth of the width of a human hair, yet electricity cannot simply jump it. So the nerve does something clever: it converts its electrical command into a chemical one, throws that chemical across the gap, and lets the muscle read it. The whole relay — spike in, twitch out — takes a couple of thousandths of a second, and your body runs it billions of times a day without you ever noticing.
The calcium trigger
When the nerve’s action potential (the electrical spike you can watch on the Nerve Impulse page) reaches the terminal, it flings open voltage-gated calcium channels in the membrane. Calcium (Ca²⁺) is far more concentrated outside the cell than inside, so it rushes in. That inward puff of calcium is the actual pull of the trigger: it is what tells the vesicles to release. No calcium, no release — which is exactly why a low blood-calcium level can make muscles behave strangely, and why the calcium step is the single most important switch in the whole junction.
Acetylcholine: the chemical word for “contract”
Inside the terminal sit thousands of tiny bubbles called synaptic vesicles, each packed with roughly 5,000 to 10,000 molecules of acetylcholine (ACh). When calcium floods in, dozens to a couple of hundred of these vesicles fuse with the membrane at once and empty their ACh into the cleft — a process built on a set of docking proteins called SNAREs. The ACh drifts across the 50-nanometre gap by simple diffusion. Acetylcholine is the same messenger your vagus nerve uses to slow your heart and your gut uses to churn food; at the muscle it means one thing only: fire.
The nicotinic receptor and the end-plate potential
On the muscle side, the membrane is thrown into deep folds — the motor end plate — carpeted with nicotinic acetylcholine receptors. Each receptor is a gated pore. When two ACh molecules land on one, it snaps open and lets sodium (Na⁺) pour into the muscle. That drives the muscle’s voltage up from its resting −90 mV toward the firing threshold of about −50 mV. A healthy junction releases far more ACh than the bare minimum needed — a cushion called the safety factor, usually threefold to fivefold — so every nerve command reliably triggers a muscle spike that peaks near +30 mV. That spike sweeps along the fibre, releases calcium from internal stores, and drives the sliding filaments that shorten the muscle.
Acetylcholinesterase: the fastest cleanup crew in the body
If ACh lingered, the muscle would stay switched on. So the cleft is studded with acetylcholinesterase (AChE), one of the fastest enzymes known — a single molecule can chop up on the order of ten thousand ACh molecules per second, clearing the message in under a millisecond. It splits ACh into choline and acetate; the nerve vacuums the choline back up and rebuilds fresh ACh for the next command. This instant reset is why you can flutter your fingers or shiver dozens of times a second. It is also the step that nerve agents attack.
The tiny leaks that proved how it works
Even at rest, a junction is never completely silent. Every so often a single vesicle drifts up and releases its packet of ACh entirely on its own, producing a barely-there blip of about 0.5 to 1 mV called a miniature end-plate potential (MEPP). In the 1950s Bernard Katz and colleagues noticed that a full nerve-triggered end-plate potential was always a whole-number multiple of one of these blips — which is how we learned that ACh is released in fixed quanta, one vesicle at a time, rather than as a smooth spray. That insight (which earned a share of the 1970 Nobel Prize) is the reason we can talk about “how many vesicles” a command releases at all. The animation lumps them together as a single green surge, but underneath, release is grainy.
Myasthenia gravis: when the receptors are attacked
Myasthenia gravis is an autoimmune disease in which the body makes antibodies against its own nicotinic receptors, destroying and blocking them. The nerve still releases a normal load of ACh, but with so few working receptors the end-plate potential is smaller and the safety factor collapses. On the first contraction the muscle may just reach threshold; with repeated use the natural, harmless dip in ACh release that every junction has is no longer covered by the cushion, and transmission starts to fail — so the hallmark is fatigable weakness that worsens through the day and recovers with rest, classically causing drooping eyelids and double vision. Because the problem is too few working receptors, the logical treatment is to make each remaining receptor see ACh for longer: cholinesterase inhibitors such as pyridostigmine block the cleanup enzyme just enough to let ACh linger and rescue the signal. Read more on the Myasthenia Gravis page.
Botulinum toxin (Botox): silencing the release
Botulinum toxin, made by Clostridium botulinum, works one step upstream: it slips into the nerve terminal and cleaves the SNARE proteins the vesicles need to fuse. Calcium still floods in, but the vesicles cannot dock, so no ACh is ever released. The muscle simply never hears the command — a flaccid paralysis. In food-borne botulism this can be fatal when it silences the breathing muscles. In tiny, purified, precisely injected doses it becomes a medicine: it relaxes an overactive muscle to soften a frown line, or calms muscle spasm, migraine, or excessive sweating.
Curare, rocuronium, and the nerve agents
The receptor itself can be jammed. Curare, the South-American arrow poison, and its modern surgical cousins rocuronium and vecuronium sit on the nicotinic receptor and block ACh from binding — a controlled, reversible paralysis that lets anaesthetists relax a patient for surgery. The opposite catastrophe is organophosphates — nerve agents like sarin and VX, and some older pesticides — which permanently poison acetylcholinesterase. With the cleanup enzyme dead, ACh is never cleared. It floods the cleft, the receptors are hammered again and again, and the muscle twitches uncontrollably before locking up in a depolarised block. Antidotes work on exactly the steps in this diagram: atropine shields the muscarinic receptors elsewhere in the body, and pralidoxime (2-PAM) can pry the poison off the enzyme if given early.
How doctors listen in on the junction
Because the whole handshake comes down to the safety factor, clinicians can test it directly. In repetitive nerve stimulation, a nerve is zapped several times a second while the muscle response is recorded; a healthy junction answers every zap identically, but in myasthenia gravis the response gets visibly smaller with each shock — a decrement that is the electrical fingerprint of a failing safety factor. A more sensitive test, single-fibre EMG, measures the slight jitter in timing between two muscle fibres served by the same nerve. Blood tests hunt for the culprit antibodies — against the acetylcholine receptor itself, or against a partner protein called MuSK that helps cluster the receptors. Each of these tests is really just a way of asking the same question this diagram asks: is enough ACh reaching enough working receptors to clear threshold, every single time?
An honest correction: Botox does not “kill” the nerve
A common worry is that a Botox injection permanently deadens the nerve or dissolves the muscle. It does neither. The toxin only disables the release machinery in the endings it reaches, and the effect is temporary: over roughly three to four months the nerve grows new sprouts, rebuilds its SNARE proteins, and function returns — which is precisely why cosmetic and medical injections have to be repeated. The flip side of that reassurance is a real caution: because it is the most potent toxin known by weight, dose and injection site matter enormously, and it should only ever be given by a trained clinician.